AI Health & Biotechnology
AI-Designed Universal Vaccine Passes First Human Trial
Cambridge researchers use AI to develop a broad-spectrum vaccine targeting future coronavirus variants.
A scientist in a laboratory holding a small vaccine vial with a digital screen in the background displaying a 3D model of a virus protein structure.
Photo: Kronos Digital News
University of Cambridge scientists successfully tested a vaccine designed using artificial intelligence to protect against various coronaviruses [1][3]. This trial marks the first time an AI-designed active vaccine component has entered human testing [1]. The vaccine aims to provide broad immunity against current and potential future variants [1][2].
The study used AI to create an antigen targeting conserved features across the coronavirus family [3]. During this first phase, the component safely stimulated immune responses in human participants [1]. Researchers believe this method could accelerate responses to future global health threats [2][3].
Editorial notes
Transparency note
AI assisted drafting. Human edited and reviewed.
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
Related stories
View all
Topics
About the author
Kronos Digital News Desk covers ai health & biotechnology and editorial analysis for Kronos Digital News.